Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Spain

 

Korian enters Spanish market, plans consolidation

European nursing home giant Korian has followed its French competitors onto the Spanish market with the acquisition of a high-end group in Andalucia. We speak to Korian's director of investor relations about why it finally made the move after years of steering clear.

Interview: Michael Sandhu, Remedium RT

After a long career at radiotherapy supplier Varian where he ended as Vice President, Global Market Development, Michael has set up his own consultancy to advise governments, international agencies and the private sector on the development of radiation therapy services in general and the best business models.  HBI asks him where the opportunities are and what they look like. 

DomusVi president quits

DomusVi's Aymar Hénin is quitting as President, despite the company's recent acquisition spree. Puzzlingly, the company says he quit on November 7 but has yet to make a public announcement despite having a large bond issue outstanding.

Spanish dental group up for sale

Despite having only formed last year, Vivanta, Spain’s third largest dental group by revenue in a very fragmented market, is for sale. We ask why it is for sale so soon, what price it might reach, and who might be in the running to buy it.

Centene bets on the survival of the Alzira model

Spanish hospital group Ribera Salud is going back to its Spanish PPP roots with the acquisition of a hospital (through its owner Centene) in Madrid, despite recently looking to Eastern Europe and LatAm for profits after its core, Alzira model ran into difficulty in Valencia.

Interview: Giuseppe Recchi, CEO, Affidea

Healthcare Europa speaks to Giuseppe Recchi, CEO of pan-European advanced diagnostic imaging specialist Affidea, to find out about the company’s foray into outpatient care, the state of AI, and plans for the future.

Dementia insurance policies in Europe within a year

Dementia policies which pay out for care are available in Japan and the USA and will be sold in Europe by the autumn of 2019 or earlier, says Peter Ohmenus, President and CEO of Dacadoo, the digital genetics wellness platform.

Find Us